[go: up one dir, main page]

NO20053788D0 - Anvendelse av lupin-konglutin for behandlingen av type II diabetes. - Google Patents

Anvendelse av lupin-konglutin for behandlingen av type II diabetes.

Info

Publication number
NO20053788D0
NO20053788D0 NO20053788A NO20053788A NO20053788D0 NO 20053788 D0 NO20053788 D0 NO 20053788D0 NO 20053788 A NO20053788 A NO 20053788A NO 20053788 A NO20053788 A NO 20053788A NO 20053788 D0 NO20053788 D0 NO 20053788D0
Authority
NO
Norway
Prior art keywords
diabetes
treatment
type
conglutin gamma
lupin conglutin
Prior art date
Application number
NO20053788A
Other languages
English (en)
Other versions
NO20053788L (no
NO333224B1 (no
Inventor
Paolo Morazzoni
Marcello Duranti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20053788D0 publication Critical patent/NO20053788D0/no
Publication of NO20053788L publication Critical patent/NO20053788L/no
Publication of NO333224B1 publication Critical patent/NO333224B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO20053788A 2003-02-11 2005-08-10 Anvendelse av lupin-konglutin gamma for behandling av type II diabetes og farmasoytiske eller ernaeringssammensetninger inneholdene lupin-konglutin gamma. NO333224B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000237A ITMI20030237A1 (it) 2003-02-11 2003-02-11 Uso della conglutina di lupino per il trattamento del
PCT/EP2004/001111 WO2004071521A1 (en) 2003-02-11 2004-02-06 The use of lupin conglutin for the treatment of type ii diabetes

Publications (3)

Publication Number Publication Date
NO20053788D0 true NO20053788D0 (no) 2005-08-10
NO20053788L NO20053788L (no) 2005-11-11
NO333224B1 NO333224B1 (no) 2013-04-15

Family

ID=32866063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053788A NO333224B1 (no) 2003-02-11 2005-08-10 Anvendelse av lupin-konglutin gamma for behandling av type II diabetes og farmasoytiske eller ernaeringssammensetninger inneholdene lupin-konglutin gamma.

Country Status (21)

Country Link
US (1) US7323441B2 (no)
EP (1) EP1605957B1 (no)
JP (2) JP2006517212A (no)
KR (2) KR20110033312A (no)
CN (1) CN1747739B (no)
AT (1) ATE391510T1 (no)
AU (1) AU2004212297B2 (no)
CA (1) CA2515607C (no)
CY (1) CY1108138T1 (no)
DE (1) DE602004012984T2 (no)
DK (1) DK1605957T3 (no)
ES (1) ES2303937T3 (no)
HK (1) HK1085927A1 (no)
IL (1) IL170200A (no)
IT (1) ITMI20030237A1 (no)
NO (1) NO333224B1 (no)
PL (1) PL214193B1 (no)
PT (1) PT1605957E (no)
RU (1) RU2339393C2 (no)
SI (1) SI1605957T1 (no)
WO (1) WO2004071521A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
WO2009144278A2 (en) 2008-05-30 2009-12-03 Fondazione Centro San Raffaele Del Monte Tabor USES OF CONGLUTIN-γ
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
CN110227145B (zh) * 2010-10-12 2024-04-02 肯苏墨艾姆维德-生物技术达思植物有限公司 抗菌蛋白
ES2989360T3 (es) * 2014-06-30 2024-11-26 Prolupin Gmbh Emulsión con proteína de lupino, uso y producción de la misma
WO2016067132A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
JPH0967252A (ja) * 1995-09-05 1997-03-11 Zenkoku Royal Jelly Kosei Torihiki Kiyougikai ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del

Also Published As

Publication number Publication date
IL170200A (en) 2010-05-31
EP1605957A1 (en) 2005-12-21
RU2005125411A (ru) 2006-01-27
CA2515607C (en) 2013-10-15
WO2004071521A1 (en) 2004-08-26
DE602004012984T2 (de) 2009-06-04
DK1605957T3 (da) 2008-08-11
KR20050106415A (ko) 2005-11-09
PL377578A1 (pl) 2006-02-06
SI1605957T1 (sl) 2008-08-31
ATE391510T1 (de) 2008-04-15
CA2515607A1 (en) 2004-08-26
KR101084434B1 (ko) 2011-11-21
EP1605957B1 (en) 2008-04-09
AU2004212297A1 (en) 2004-08-26
JP5504301B2 (ja) 2014-05-28
US7323441B2 (en) 2008-01-29
RU2339393C2 (ru) 2008-11-27
JP2006517212A (ja) 2006-07-20
CN1747739A (zh) 2006-03-15
ES2303937T3 (es) 2008-09-01
AU2004212297B2 (en) 2009-09-10
NO20053788L (no) 2005-11-11
CN1747739B (zh) 2013-04-17
PL214193B1 (pl) 2013-06-28
JP2012153715A (ja) 2012-08-16
DE602004012984D1 (de) 2008-05-21
HK1085927A1 (en) 2006-09-08
ITMI20030237A1 (it) 2004-08-12
US20060142185A1 (en) 2006-06-29
PT1605957E (pt) 2008-06-27
KR20110033312A (ko) 2011-03-30
CY1108138T1 (el) 2014-02-12
NO333224B1 (no) 2013-04-15

Similar Documents

Publication Publication Date Title
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
WO2001028356A3 (en) Food supplement for increasing lean mass and strength
PL1898724T3 (pl) Preparat odżywczy dla niemowląt z hydrolizowanymi białkami
NO20050896L (no) Probiotika for neuromuskulaere funksjoner i tarmen
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
DE60012301D1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
AU2003207417A1 (en) Use of tryptophan rich peptides
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
IL172898A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
TW200513197A (en) Amino acid supplementation for a healthy microbiota ecosystem
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
JP2017057147A (ja) ニンニク等、低塩分濃度の味噌、及びビタミンｂ１を含有する組成物
AR045745A1 (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
SI1581239T1 (sl) Zgodnja uporaba ekstrakta listov rdeče vinske trte
MY184130A (en) Peptidic growth hormone secretagogues analog compounds and preparations thereof
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
EP1407677A3 (en) Compositions comprising partly-hydrolized fish gelatin and use thereof
ATE405584T1 (de) Arginin/lysin-angereicherte peptide
JP2017043593A (ja) 黒ニンニク及びビタミンｂ１を含有する組成物

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees